 Can-Fite BioPharma Ltd NYSE: CANF has expanded its Phase 2 COVID-19 study of Piclidenoson to two European countries, Romania and Bulgaria. The randomized, double-blind, placebo-controlled study evaluates Piclidenoson plus standard supportive care SSC vs. 